This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Success in Controlling Outbreaks in an ICU Using CDC Toolkit Interventions

Infections due to carbapenem-resistant Enterobacteriaceae (CRE) are on the rise globally. On the CDC’s Safe Healthcare Blog, Dr. Kyle Enfield, assistant hospital epidemiologist and medical director of the Medical Intensive Care Unit at the University of Virginia Health System, describes how his team implemented infection control interventions to assess the prevalence of CRE and extensively drug-resistant Acinetobacter baumannii in the unit. This set of interventions became recommended practice in the CDC’s 2012 Carbapenem-resistant Enterobacteriaceae Toolkit.

As a result, the CRE incidence came down to 0.1 percent of patient days and drug-resistant A. baumannii was eliminated in the unit. These findings were published in the July 2014 issue of Infection Control and Hospital Epidemiology.

Has your facility implemented the CRE Toolkit? Let the CDC know by posting a comment on the Safe Healthcare Blog.

comments powered by Disqus